Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Sharon Kleyne Applauds China IP Protection Effort
  • USA - English


News provided by

Bio-Logic Aqua® Research – Water Life Science® -Rogue Media

Jan 11, 2017, 06:00 ET

Share this article

Share toX

Share this article

Share toX

Bio-Logic Aqua® Research Water Life Science® Founder Sharon Kleyne Misting People with Nature's Tears® EyeMist® at Tiananmen Square in Beijing, China
Bio-Logic Aqua® Research Water Life Science® Founder Sharon Kleyne Misting People with Nature's Tears® EyeMist® at Tiananmen Square in Beijing, China

Grants Pass, OR (PRWEB) January 11, 2017 -- As premiere American water advocate and researcher, Sharon Kleyne, guides her company, Bio-Logic Aqua® Research Water Life Science®, and its signature product, Natures Tears® EyeMist® into the vast Chinese marketplace, she called admiring attention on air to that government’s effort to clean up a major international scandal that threatens the global economy.

Sharon Kleyne, host of the nationally syndicated radio program, The Sharon Kleyne Hour Power of Water, Global Climate Change and Your Health on Voice America, specifically took to the air to encourage Chinese leaders and business people to continue to ramp up their attacks on unscrupulous counterfeiters who often flood Chinese markets with inferior, knock-off products. “Thus kind of counterfeiting,” said Kleyne, “is the ultimate attack against the protection and integrity of a country’s or a company’s IP, and it must be stopped.” Fortunately, Kleyne points out, that is beginning to happen as Chinese officials and leaders of major enterprises (such as Jack Ma at Ali Baba) aggressively file lawsuits against counterfeiters, who will be punished and driven out of business.

“China’s vast middle class is growing exponentially,” said Sharon Kleyne, “and with that growth comes more sophisticated taste. For instance,” Kleyne continued, “Chinese consumers realize now that cheaper, knock-off counterfeit products possess much less quality than the real thing. Those consumers want the real thing, and they want to be protected against IP pirates.”

Sharon Kleyne is always educating people about the dangers and supplementation of dry eye disease, the current global water crisis and the health dangers associated with dehydration due to excess evaporation of the earth’s water vapor. As she always does, Kleyne encouraged people to experience a new, healthy Water Life Science® lifestyle and visit http://www.biologicaqua.com/ for more information. She also urged her listeners to educate themselves about the perils of counterfeiting and IP abuse. “Quality products can be hard to come by,” said Kleyne, “when counterfeiters and IP thieves are allowed to run wild.” Yet now, Kleyne says that she is increasingly optimistic about the steps she sees being taken by the Chinese government and business leaders.

Over more than two decades, Sharon Kleyne has earned an international reputation as the global expert on dehydration of earth’s fresh water and dehydration of the eyes and skin as a result of the excessive evaporation of the body’s water vapor. “From the moment we leave our mother’s water-womb and are born,” Kleyne said, “we begin to evaporate, or dry out, a process that continues until we die. In order to sustain excellent health and prolong life,” Kleyne continued, “one must supplement eyes and skin on a daily basis. This must be done to replenish the evaporating water vapor.” Kleyne reminded her radio audience, for example, that dry eye disease exceeds all other diseases that ophthalmologists and optometrists diagnose and treat each year, and the numbers continue to climb with aging populations. Dry eye afflicts more than 30 million Americans and an astonishing 250 million Chinese each year. Dry eye symptoms include blurred vision, redness, burning, itching, stinging, a gritty sensation and watery eyes. These symptoms are triggered by a number of causes including pollution, allergies, post-menopausal changes, windy conditions, computer use, reading, television viewing and artificial environments (air conditioning, central heating). Dry eye disease occurs when the tear film lens, which is 99% water, loses moisture due to evaporation.

“Protecting our IP,” Sharon Kleyne said, “has allowed us to develop quality products that supplement the eyes and skin. For instance,” she said, “Nature’s Tears® EyeMist® is applied with a personal hand-held humidifying device emitting a pure, pH balanced, 100% Trade Secret tissue culture grade water in a patented micron mist.” Nature’s Tears® EyeMist® is the only product on the international market that supplements the eye’s tear film, which is 99 percent water, and it is endorsed by more than 22,000 ophthalmologists and optometrists nationwide. The product was successfully test-marketed in more than 70,000 outlets. As this product launches in China, Kleyne said she was thrilled to see the government crack down on potential knock-off artists and counterfeiters. “Everyone benefits,” said Kleyne, “especially consumers.”

Mikaylah Roggasch, Bio-Logic Aqua® Research – Water Life Science® -Rogue Media, http://www.biologicaqua.com, +1 (800) 367-6478, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.